Preclinical antitumor activity of a novel folate-targeted dual drug conjugate.
about
Structural basis for molecular recognition of folic acid by folate receptorsA current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancerDevelopment and evaluation of a new modular nanotransporter for drug delivery into nuclei of pathological cells expressing folate receptors.Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors and the proton-coupled folate transporter over theFunctionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery.Intracellular trafficking considerations in the development of natural ligand-drug molecular conjugates for cancer.Pharmacological characterization of chemically synthesized monomeric phi29 pRNA nanoparticles for systemic delivery.Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors.The antifolatesGlucose conjugation for the specific targeting and treatment of cancer.Clinical pharmacokinetics and exposure-toxicity relationship of a folate-Vinca alkaloid conjugate EC145 in cancer patientsSynthesis and biological activity of a novel series of 6-substituted thieno[2,3-d]pyrimidine antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors over the reduced folate carrier and proton-coupled folate tMurine portal vein catheterization to analyze liver-directed therapies.Subcellular targeting: a new frontier for drug-loaded pharmaceutical nanocarriers and the concept of the magic bullet.The current state of pemetrexed in ovarian cancer.Guiding principles in the design of ligand-targeted nanomedicines.Small Molecules for Active Targeting in Cancer.Soft structure formation and cancer cell transport mechanisms of a folic acid-dipeptide conjugate.Folate-mediated chemotherapy and diagnostics: An updated review and outlook.In vitro and in vivo evaluation of (99m)Tc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors.Folate Receptor-Positive Gynecological Cancer Cells: In Vitro and In Vivo Characterization.Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance.Internal Targeting and External Control: Phototriggered Targeting in Nanomedicine.Accessing Structurally Diverse Near-Infrared Cyanine Dyes for Folate Receptor-Targeted Cancer Cell Staining.Phase I clinical trial of 99mTc-etarfolatide, an imaging agent for folate receptor in healthy Japanese adults.Identification of a peptide for folate receptor alpha by phage display and its tumor targeting activity in ovary cancer xenograft.Advances in targeting the folate receptor in the treatment/imaging of cancers.A bivalent small molecule-drug conjugate directed against carbonic anhydrase IX can elicit complete tumour regression in micePreparation and Characterization of Folate Targeting Magnetic Nanomedicine Loaded with Cisplatin
P2860
Q24307935-3DC27DFB-0132-4CBC-BBC7-D5555E884D46Q26781856-0C1B581E-95BF-42E2-BC7C-79012A80B288Q33627894-C86AA611-F4CA-4947-8CC0-3DE81DFFA026Q33720633-871AE631-476A-46DD-BB18-F9B2692BF409Q33925595-A99C3726-F30A-4959-AF86-9B1AF5B9B0F1Q34751465-D03CEAC5-0241-4E40-86F5-ED66952E4EB5Q35086107-F41E97CE-9228-4BBF-8C83-9B333A3DDB9EQ35780797-E7BDC013-82A7-432C-AF2F-1DC9B7442BA2Q37183495-854FF83B-2CA8-44AB-86C2-9B193E4A6101Q37200539-BB830903-514F-4C96-A582-BCA8F2154CA7Q37252523-441FF4F9-2ECF-4FB3-8D59-689F148416C2Q37313482-8D928FBE-BCD8-448E-97AD-B4D4D1254BDEQ37315443-BF733625-8C15-4DE3-9DFE-5526CB5737F2Q37587184-2659161E-AD8A-4D74-ABEA-53AAF651473FQ38125259-C1CABBC0-110F-4400-9E89-D0E314C8674CQ38189490-C4E857A1-14FC-4D2A-95B7-CB72008008B1Q38780383-9BFE8F55-9DB9-4F8F-8590-FFBDE2C48074Q38913669-FCC30BBC-FCBF-4AF0-870B-B6489144032DQ39149880-6E2EB3B3-6B2D-4EFF-8C26-70E997672CF2Q39572435-A8B1CA1E-13CD-42F7-AE37-08C87AA71231Q42366884-8668D18D-B998-4612-B831-2B85AE155E5EQ45331579-2B757AAD-8B8F-4ECF-AB92-9A20B68AEA37Q48122048-08E1E45F-B25D-4F9A-A65B-189060CFE570Q48364996-FCE097E5-ADFD-4656-95A3-32162F2DE876Q53396871-DF914431-D8D4-41AD-BB10-C128E7AEAFA2Q55061789-ED281392-3072-4FF9-8C88-1ECE30BD56FDQ55315165-8B45FC38-EFCB-4FFB-A8AB-CF909591F622Q57911942-EF981395-1974-4465-B3D7-20C34728A9E6Q58910111-73BECEC8-4F41-49A9-B435-B969983CC7AD
P2860
Preclinical antitumor activity of a novel folate-targeted dual drug conjugate.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Preclinical antitumor activity of a novel folate-targeted dual drug conjugate.
@ast
Preclinical antitumor activity of a novel folate-targeted dual drug conjugate.
@en
Preclinical antitumor activity of a novel folate-targeted dual drug conjugate.
@nl
type
label
Preclinical antitumor activity of a novel folate-targeted dual drug conjugate.
@ast
Preclinical antitumor activity of a novel folate-targeted dual drug conjugate.
@en
Preclinical antitumor activity of a novel folate-targeted dual drug conjugate.
@nl
prefLabel
Preclinical antitumor activity of a novel folate-targeted dual drug conjugate.
@ast
Preclinical antitumor activity of a novel folate-targeted dual drug conjugate.
@en
Preclinical antitumor activity of a novel folate-targeted dual drug conjugate.
@nl
P2093
P356
P1476
Preclinical antitumor activity of a novel folate-targeted dual drug conjugate.
@en
P2093
Alicia Dawson
Christopher P Leamon
Elaine Westrick
Hari Krishna Santhapuram
Iontcho R Vlahov
Joseph A Reddy
Marilynn Vetzel
Ryan Dorton
P304
P356
10.1021/MP070049C
P407
P577
2007-09-18T00:00:00Z